Is Cancer Curable?

Cancer, known medically as a malignant neoplasm, is a term for a large group of different diseases, all involving unregulated cell growth. In cancer, cells divide and grow uncontrollably, forming malignant tumors, and invade nearby parts of the body. The cancer may also spread to more distant parts of the body through the lymphatic system or bloodstream. Not all tumors are cancerous. Benign tumors do not grow uncontrollably, do not invade neighbouring tissues, and do not spread throughout the body. Healthy cells control their own growth and will destroy themselves if they become unhealthy.

Determining what causes cancer is complex, and it is often impossible to assign a specific cause for a specific cancer. Many things are known to increase the risk of cancer, including tobacco use, infection, radiation, lack of physical activity, poor diet and obesity, and environmental pollutants. These can directly damage genes or combine with existing genetic faults within cells to cause the disease. A small percentage of cancers, approximately five to ten percent, are entirely hereditary.

Fighting Cancer with Nutrition

Andrew Saul, PhD talks about the importance and practical application of Nutritional Therapy in the treatment of Cancer.  His discussions on Orthomolecular Nutrion has saved thousands of lives. We simply can’t afford to ignor his words!

Doctor Yourself – Dr. Andrew Saul’s Web Site

Other Examples of Alternative Cancer Therapies

• Healing Your Body with the Gerson Therapy
  With its whole-body approach to healing, the Gerson Therapy naturally reactivates your body’s magnificent ability to heal itself – with no damaging side-effects. Over 200 articles in respected medical literature, and thousands of people cured of their “incurable” diseases document the Gerson Therapy’s effectiveness. The Gerson Therapy is one of the few treatments to have a 60 year history of success.
• Dr. Robert C. Beck video and Beck Protocol [from http://www.bobbeck.com/ ]
• Dr. Schulze – Alternative and Natural Healing for Powerful Health
  For me personally, in one word, Health is FREEDOM. Disease and illness rob you of your freedom… and your money. Being healthy feels great, and it gives you the freedom to live your life the way you want, and the ENERGY to do all of the things that you want to do, and the VITALITY to have all of the fun that you want to have, and to really, really enjoy your life, to your fullest potential. If you are ready to have health, and a life like this…WELCOME!
• Cannabis Sativa (hemp/marijuana) oil

Note: If you are aware of other alternative cancer therapy, feel free to mention it the Comments section.

Suppressed Medical Discovery: Dr. Robert C. Beck ( Cancer,AIDS, anything viral)

“Alternating Current Supplied Electrically Conductive Method and System for Treatment of Blood and/or Other Body Fluids and/or Synthetic Fluids with Electric Forces.”

In 1990, an astounding discovery was reported at Albert Einstein College of Medicine in NYC by Drs. Kaali and Wyman, resulting in Patent … all » No. 5,188,738 being issued in 1993 entitled “Alternating Current Supplied Electrically Conductive Method and System for Treatment of Blood and/or Other Body Fluids and/or Synthetic Fluids with Electric Forces.”. Their research work involved an in vitro & in vivo human Blood Electrification process, which electronically sterilizes the blood, resulting in all known pathogens, including bacteria, viruses, parasites, and fungus, being completely eliminated! Their research had been anticipated 24 years earlier in 1973 with the research involved in Patent No. 3,753,886. Not surprisingly though, due to the stranglehold, that the Pharmaceutical Cartel has in the U.S., this revolutionary clinical data was almost totally suppressed. Other than a few News Articles such as the Science News: Mar. 30, `91 pg. 207, Longevity: Dec. `92/pg. 14, and Houston Post: Mar. 20, ’91 /Sect. A-10, plus the Patent No. 5,188,738, there has been a complete BLACKOUT since then in the News Media about this powerful medical technology.

Watch this important video >>

[ Source: http://fadi420.wordpress.com/2007/01/27/suppressed-medical-discovery-dr-robert-c-beck-canceraids-anything-viral/ ]

Patent No. 5,188,738 Info from Gov. site [ Source >> ]
Note: To search any US Patent by number go to http://patft.uspto.gov/netahtml/PTO/srchnum.htm

Inventors:     Kaali; Steven (Dobbs Ferry, NY), Schwolsky; Peter M. (Washington, DC)

Alternating current supplied electrically conductive method and system for treatment of blood and/or other body fluids and/or synthetic fluids with electric forces

Abstract

A new alternating current process and system for treatment of blood and/or other body fluids and/or synthetic fluids from a donor to a recipient or storage receptacle or in a recycling system using novel electrically conductive treatment vessels for treating blood and/or other body fluids and/or synthetic fluids with electric field forces of appropriate electric field strength to provide electric current flow through the blood or other body fluids at a magnitude that is biologically compatible but is sufficient to render the bacteria, virus, parasites and/or fungus ineffective to infect or affect normally healthy cells while maintaining the biological usefulness of the blood or other fluids. For this purpose low voltage alternating current electric potentials are applied to the treatment vessel which are of the order of from about 0.2 to 12 volts and produce current flow densities in the blood or other fluids of from one microampere per square millimeter of electrode area exposed to the fluid being treated to about two milliamperes per square millimeter.

Description

This invention relates to novel electrically conductive methods and systems employing electrically conductive vessels provided with electrically conductive surfaces for use in subjecting blood and/or other body fluids and/or synthetic fluids such as tissue culture medium to direct treatment by alternating current electric forces.

BACKGROUND PROBLEM

It is now well known in the medical profession and the general public that blood collected in a blood bank from a large number of donors may be contaminated by contaminants such as bacteria, virus, parasites and/or fungus obtained from even a single donor. While screening of donors has done much to alleviate this problem, the screening of donors can and does miss occasional donors whose blood is unfit for use. When this occurs and the unfit blood is mixed with otherwise usable blood, the entire batch must be discarded for transfusion purposes. Because of this problem, the present invention has been devised to attenuate any bacteria, virus (including the AIDS HIV virus) parasites and/or fungus contained in blood contributed by a donor to the point that any such contaminant is rendered ineffective for infecting a normally healthy human cell, but does not make the blood biologically unfit for use in humans. Similar problems exist with respect to treatment of other body fluids, such as amniotic fluids. The treatment method and system is also applicable to mammals other than humans.

In addition to the above, there is a need for methods and systems for the treatment of blood and other body fluids both in in-situ processing wherein the treated blood and/or other body fluids are withdrawn from the body, treated and then returned to the body in a closed loop, recirculating treatment process that is located near but outside the patient’s body, or the treatment can be effected through implanted treatment system components.

In co-pending United States application serial No. 07/615,800 entitled “Electrically Conductive Methods and Systems for Treatment of Blood and Other Body Fluids with Electric Forces”-Steven Kaali and Peter M. Schwolsky, inventors, filed concurrently and co-pending with this application, a similar treatment method and system employing direct current excitation potentials is described and claimed. The disclosure of co-pending application Ser. No. 07/615,800 hereby is incorporated into this application in its entirety.

SUMMARY OF INVENTION

The present invention provides new electrically conductive methods and systems using alternating electric current excitation potentials for treating blood and/or other body fluids, such as amniotic fluids, and/or synthetic fluids such as tissue culture medium from a donor to a transfusion recipient or to a storage receptacle, or for recirculating a single donor’s or patient’s blood or other body fluids. The treatment can be accomplished in a treatment system external of the body or by implant devices for purging contaminants using a novel electrically conductive vessel for direct electric treatment of blood or other body fluids, such as amniotic fluids, with alternating current electric field forces of appropriate electric field strength to attenuate such contaminants to the extent that bacteria, virus, fungus, and/or parasites contained in the blood or other body fluids are rendered ineffective to infect and/or affect normally healthy human cells. The treatment, however, does not render the blood or other body fluids biologically unfit for use in humans or other mammals after the treatment. The new methods and systems according to the invention achieve these ends without requiring time consuming and expensive processing procedures and equipment in addition to those normally required in the handling of blood or other body fluids or synthetic fluids. The invention can be used to achieve the electric field force treatment during the normally occurring transfer processing from a donor to a recipient or to a collection receptacle, or recirculation of a single donor’s or patient’s blood or other body fluids, such as amniotic fluids.

What is claimed is:

1. An electrically conductive vessel for direct electric treatment of bacteria, and/or virus, and/or parasites and/or fungus entrained in blood and/or other body fluids and/or synthetic fluids contained within or flowing through the vessel in the presence of electric field forces, said electrically conductive vessel being fabricated with only biologically compatible material contacting the fluid being treated and with an array of at least two or more spaced-apart, opposed electrically conductive electrode segments formed of biologically compatible conductive material on or in the interior surface of the vessel and exposed to blood or other fluids contained in or flowing through the vessel, said electrically conductive electrode segments being electrically isolated from each other and extending over or through a portion of the length of the vessel, and means for applying low voltage alternating current non-biologically damaging electric potentials to the electrically conductive electrode segments whereby electrical field forces are produced between the electrically conductive electrode segments that induce biologically compatible current flow through the blood and/or other fluids contained in or flowing through the vessel so as to attenuate bacteria, virus, parasites and/or fungus contained in the blood and/or other fluids by the action of the electric current flow therethrough to thereby render the bacteria, virus, parasites and/or fungus ineffective while not impairing and maintaining the biological usefulness of the fluids.

2. An electrically conductive vessel according to claim 1 wherein the low voltage alternating current electric potentials are in the range from about 0.2 volts to 12 volts and induce electric current flow densities in the blood or other fluids of from one microampere per square millimeter (1 .mu.A/mm.sup.2) to about two milliamperes per square millimeter (2 mA/mm.sup.2).

3. An electrically conductive vessel according to claim 2 wherein the vessel is in the form of tubing and is inserted in a flow-thru blood treatment system between a hypodermic needle employed to withdraw and/or supply blood from a donor and/or to a recipient and/or a blood storage receptacle or to a patient in a blood recycling system.

4. An electrically conductive vessel according to claim 2 wherein the vessel is part of a system and is in the form of tubing and a blood pump is inserted in the tubing between a donor and a recipient or a receptacle, and the system further includes means for electrically isolating the blood pump from the electrically conductive vessel, means for regulating blood flow rate from the blood pump output and means for maintaining electrical continuity throughout a desired length of the conductive vessel.

5. An electrically conductive vessel according to claim 2 wherein the vessel is in the form of tubing and the electrically conductive electrode segments are in the form zebra stripes which extend longitudinally parallel with the longitudinal axis of the tubing with the alternate electrically conductive electrode stripes being separated by alternate electrically insulating stripes for electrically isolating the alternate electrically conductive electrode stripes one from the other, a first set of alternate ones of the electrically conductive electrode stripes being electrically connected in common to a first annular terminal buss formed on and circumferentially surrounding the tubing and electrically isolated from the remaining second set of alternate electrically conductive electrode stripes, said first annular terminal buss being designed for connection to one supply terminal of a source of alternating current electric excitation potential, and a second annular terminal buss circumferentially surrounding the tubing and electrically connected to the remaining second set of alternate electrically conductive electrode stripes, said second annular terminal buss being electrically isolated from the first annular terminal buss and the first set of alternate electrically conductive electrode stripes and being designed for connection to a second supply terminal of a source of alternating current electric excitation potential.

6. Electrically conductive tubing according to claim 5 wherein the tubing is inserted in a flow-thru blood treatment system between a hypodermic needle employed to withdraw and/or supply blood from a donor and/or to a recipient and/or a blood storage receptacle or to a patient in a blood recycling system.

7. Electrically conductive tubing according to claim 5 wherein a blood pump is inserted in the tubing between a donor and a recipient and/or a receptacle, and the tubing is a part of a system which further includes means for electrically isolating the blood pump from the electrically conductive tubing, means for regulating blood flow rate from the blood pump output, and means for electrically interconnecting the input and output sides of the tubing around the blood pump and the blood flow regulating means whereby electrical continuity is maintained throughout a desired length of the tubing.

8. An electrically conductive tubing according to claim 2 wherein the vessel is in the form of tubing and the electrically conductive electrode segments are in the form of zebra stripes which extend radially around the inside diameter of the tubing in alternating conductive and insulating annular bands whereby alternate conductive bands are electrically isolated one from the other by respective insulating bands, a first set of alternate ones of the electrically conductive annular electrode stripes being electrically connected in common to a first longitudinally extending terminal buss that is formed on the tubing in parallel with the longitudinal axis thereof and electrically isolated from the remaining second set of alternate electrically conductive annular electrode stripes, said first longitudinally ext ending terminal buss being designed for connection to a first supply terminal of a source of alternating current electric excitation potential, and a second longitudinally extending terminal buss electrically connected to the remaining second set of alternate electrically conductive annular electrode stripes, said second longitudinally extending terminal buss being electrically isolated from the first longitudinally extending terminal buss and the first set of alternate electrically conductive annular electrode stripes and being designed for connection to a second supply terminal of a source of alternating current electric excitation potential.

9. Electrically conductive tubing according to claim 8 wherein the tubing is inserted in a flow-thru blood treatment system between a hypodermic needle employed to withdraw and/or supply blood from a donor and/or to a recipient and/or a blood storage receptacle or to a patient in a blood recycling system.

10. Electrically conductive tubing according to claim 9 wherein a blood pump is inserted in the tubing between a donor and a recipient and/or a receptacle, and the tubing is part of a system that further includes means for electrically isolating the blood pump from the electrically conductive tubing, means for regulating blood flow from the output of the blood pump, and means for electrically interconnecting the input and output sides of the tubing around the blood pump and blood flow regulating means whereby electrical continuity is maintained through a desired length of the tubing.

11. An electrically conductive vessel according to claim 2 wherein the walls of the vessel itself are formed from electrically conductive polymer material that is compatible with human tissue and blood and/or other body fluids with the electrically conductive portions being formed into desired patterns of spaced apart electrically conductive electrode segments physically interconnected by integrally formed electrically insulating tubing walls portions which electrically isolate a first array of electrode segments from a second array of electrode segments.

12. An electrically conductive vessel according to claim 11 wherein the vessel is in the form of tubing and the electrically conductive electrode segments are in the form of zebra stripes which extend longitudinally parallel with the longitudinal axis of the tubing with the alternate electrically conductive electrode stripes being separated by alternate electrically insulating stripes for electrically isolating the alternate electrically conductive electrode stripes one from the other, a first set of alternate ones of the electrically conductive electrode stripes being electrically connected in common to a first annular terminal buss formed on and circumferentially surrounding the tubing and electrically isolated from the remaining second set of alternate electrically conductive electrode stripes, said first annular terminal buss being designed for connection to one supply terminal of a source of alternating current electric excitation potential, and a second annular terminal buss circumferentially surrounding the tubing and electrically connected to the remaining second set of alternate electrically conductive electrode stripes, said second annular terminal buss being electrically isolated from the first annular terminal buss and the first set of alternate electrically conductive electrode stripes and being designed for connection to a second supply terminal of a source of alternating current electric excitation potential.

13. Electrically conductive tubing according to claim 12 wherein the tubing is inserted in a flow-thru blood treatment system between a hypodermic needle employed to withdraw and/or supply blood from a donor and/or to a recipient and/or a blood storage receptacle or to a patient in a blood recycling system.

14. Electrically conductive tubing according to claim 13 wherein a blood pump is inserted in the tubing between a donor and a recipient and/or a receptacle, and the tubing is part of a system which further includes means for electrically isolating the blood pump from the electrically conductive tubing, means for regulating blood flow from the output of the blood pump, and means for electrically interconnecting the input and output sides of the tubing around the blood pump and blood flow regulating means whereby electrical continuity is maintained throughout a desired length of the tubing.

15. An electrically conductive vessel according to claim 11 wherein the vessel is in the form of tubing and the electrically conductive electrode segments are in the form of zebra stripes which extend radially around the inside diameter of the tubing in alternating conductive and insulating annular bands whereby alternate conductive bands are electrically isolated one from the other by respective insulating bands, a first set of alternate ones of the electrically conductive annular electrode stripes being electrically connected in common to a first longitudinally extending terminal buss that is formed on the tubing in parallel with the longitudinal axis thereof and electrically isolated from the remaining second set of alternate electrically conductive annular electrode stripes, said first longitudinally extending terminal buss being designed for connection to a first supply terminal of a source of alternating current electric excitation potential, and a second longitudinally extending terminal buss electrically connected to the remaining second set of alternate electrically conductive annular electrode stripes, said second longitudinally extending terminal buss being electrically isolated from the first longitudinally extending terminal buss and the first set of alternate electrically conductive annular electrode stripes and being designed for connection to a second supply terminal of a source of alternating current electric excitation potential.

16. Electrically conductive tubing according to claim 15 wherein the tubing is inserted in a flow-thru blood treatment system between a hypodermic needle employed to withdraw and/or supply blood from a donor and/or to a recipient and/or a blood storage receptacle or a patient in a blood recycling system.

17. Electrically conductive tubing according to claim 16 wherein a blood pump is inserted in the tubing between a donor and a recipient and/or a receptacle, and the tubing is part of a system that further includes means for electrically isolating the blood pump from the electrically conductive tubing, means for regulating blood flow from the output of the blood pump, and means for electrically interconnecting the input and output sides of the tubing around the blood pump and the blood flow regulating means whereby electrical continuity is maintained throughout a desired length of the tubing.

18. A fluid treatment process for attentuating bacteria, and/or virus, and/or parasites, and/or fungus, existing in blood and/or other body fluids and/or synthetic fluids within a treatment vessel having only biologically compatible internal and conductive electrode surfaces therein contacting fluid being treated thereby maintaining the biological usefulness of the blood or other fluids being treated comprising subjecting the fluid within the treatment vessel to low voltage, low alternating current electric field forces within non-biologically damaging electric field forces for producing a biologically compatible current flow through the blood or other fluids for a predetermined period of time sufficient to attenuate bacteria and/or virus, and/or parasites and/or fungus contained in the blood or other fluids to thereby render them ineffective while maintaining the biological usefulness of the fluids being treated.

19. The product of the process according to claim 18.

20. A fluid treatment process according to claim 18 wherein the low voltage alternating current electric potentials are in the range from about 0.2 to 12 volts and induce electric current flow densities in the blood or other fluids of from one microampere per square millimeter (1 .mu.A/mm.sup.2) to about two milliamperes per square millimeter (2 mA/mm.sup.2).

21. The product of the process according to claim 20.

22. A fluid treatment system for attentuating bacteria, and/or virus, and/or parasites, and/or fungus existing in blood and/or other body fluids and/or synthetic fluids being treated without biological damage to the blood or other fluids comprising an electrically conductive vessel formed at least in part of biologically compatible conductive material for contacting blood or other fluids to be treated, means for subjecting the blood or other fluids within the conductive vessel to low voltage, low alternating current electric field forces for producing biologically compatible current flow through the blood or other fluids for a predetermined period of time sufficient to attenuate bacteria and/or virus, and/or parasites, and/or fungus contained in the blood or other fluids to thereby render such contaminants ineffective while maintaining the biological usefulness of the blood or other fluids.

23. A fluid treatment system according to claim 22 wherein the low voltage alternating current electric potentials are in the range from about 0.2 to 12 volts and produce electric current flow densities in the blood or other body fluids of from one microampere per square millimeter (1 .mu.A/mm.sup.2) to about two milliamperes per square millimeter (2 A/mm.sup.2).

24. A fluid treatment system according to claim 22 wherein the system comprises a plurality of components including an electric power source all of which the miniaturized and implanted in the body of a patient being treated to form a closed loop, continuous recirculating body fluid treatment system.

25. A fluid treatment system according to claim 22 wherein the conductive vessel is in the form of an open ended tube to allow flow-thru treatment of blood and other fluids and is miniaturized along with an electric power source for supply of alternating current electric potentials thereto whereby the system may be implanted in human beings and other mammals to operate as a continuous recirculating fluid treatment process.

26. A fluid treatment system according to claim 22 wherein the conductive vessel in the vicinity of the spaced-apart opposed electrically conductive electrode segments is provided with an enlarged cross sectional area wherein enlarged electrically conductive electrode segment surface areas are provided to act on the blood or other fluids flowing through the vessel thereby increasing the through-put and/or effectiveness of the treatment accomplished within the vessel for a given dwell time.

27. A body fluid treatment system according to claim 26 wherein the electrically conductive vessel comprises an enlarged rectangular-shaped body of electrical insulating material having a plurality of parallel, longitudinally extending tubular openings formed all the way through the insulating material from one end to the other and having spaced-apart electrically conductive metal strips secured to respective opposite sides of all of the tubes in opposed, parallel relationship, one set of corresponding conductive strips of all of the tubes extending out of the ends of each tube on one side or end of the body of electrical insulating material and contacting a conductive surface forming a terminal buss for all conductive strips of the set, and the remaining set of conductive strips projecting out of the opposite ends of the respective tubes on the opposite end of the insulating block to engage a conductive terminal surface, and header reservoirs formed on each of the ends of the body of electrical insulating material into which the ends of the tubular openings are connected, each header having a respective inlet or outlet opening for supply of blood and/or other fluids for treatment thereto.

28. A fluid treatment system according to claim 27 wherein the enlarged insulating clock member is cylindrically shaped and the header reservoirs at each end of the block member are correspondingly cylindrically shaped.

29. A fluid treatment system according to claim 27 wherein selectively operated gas vents are provided in the top of the respective header reservoirs of the electrically conductive vessel.

30. A fluid treatment system according to claim 26 wherein the electrically conductive vessel is in the form of an enlarged cross sectional area treatment vessel of substantially greater cross sectional area than the inlet and outlet conduits supplying body fluids to be treated to the vessel and wherein the enlarged cross sectional area vessel is included in a blood transfer system between a hypodermic needle employed to withdraw and/or supply blood from a donor and/or to a recipient and/or a blood storage receptacle or to a patient in a continuous flow-thru blood recycling system.

31. A fluid treatment system according to claim 30 wherein a blood pump is inserted in the flow path of the blood or other fluid either to or from the enlarged cross sectional area vessel, or both, and are located in a tubing system between the donor and recipient or receptacle, and the system further includes means for regulating blood flow rate from or to the enlarged cross sectional area treatment vessel via the inlet or outlet pumps or both.